Table 4.
CQ7a | Asymmetric placebo (n = 20) | BRNS clear (n = 20) | Asymmetric butterfly (n = 19) |
---|---|---|---|
Mean (SD) at baseline | 19.20 (5.05) | 18.70 (4.35) | 16.79 (5.31) |
Day 7 | |||
LS mean change from baseline (95% CI) | − 5.14 (− 7.53 to − 2.74) | − 6.85 (− 9.28 to − 4.41) | − 8.18 (− 10.75 to − 5.62) |
P value for comparison with placebo | – | P = 0.2986 | P = 0.0764 |
P value for comparison with BRNS | – | – | P = 0.4258 |
Day 14 | |||
LS mean change from baseline (95% CI) | − 5.10 (− 7.37 to − 2.83) | − 8.04 (− 10.34 to − 5.73) | − 6.92 (− 9.35 to − 4.49) |
P value for comparison with placebo | – | P = 0.0623 | P = 0.2607 |
P value for comparison with BRNS | – | – | P = 0.4820 |
BRNS Breathe Right Nasal Strip, CI confidence interval, CQ7 Congestion Quantifier 7, ITT intent-to-treat, LS least square, SD standard deviation
a CQ7 was calculated by adding the responses to the seven items on the CQ7 questionnaire for each subject. Each question was rated on a scale of 0 = none of the time, 1 = a little of the time, 2 = some of the time, 3 = most of the time, and 4 = all of the time